STURIALE, LUISELLA
 Distribuzione geografica
Continente #
AS - Asia 1.800
NA - Nord America 967
EU - Europa 572
SA - Sud America 326
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.707
Nazione #
US - Stati Uniti d'America 930
SG - Singapore 748
CN - Cina 395
BR - Brasile 272
IT - Italia 214
VN - Vietnam 211
HK - Hong Kong 175
FR - Francia 122
KR - Corea 68
NL - Olanda 67
BD - Bangladesh 45
DE - Germania 40
JP - Giappone 40
FI - Finlandia 36
GB - Regno Unito 31
IN - India 31
AR - Argentina 24
ZA - Sudafrica 20
CA - Canada 12
ID - Indonesia 12
MX - Messico 12
CO - Colombia 8
PL - Polonia 8
TR - Turchia 8
EC - Ecuador 7
ES - Italia 7
IL - Israele 7
IQ - Iraq 7
RU - Federazione Russa 7
SA - Arabia Saudita 7
TH - Thailandia 7
PE - Perù 6
SE - Svezia 6
MY - Malesia 5
PH - Filippine 5
PK - Pakistan 5
AT - Austria 4
DZ - Algeria 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
IR - Iran 3
JM - Giamaica 3
LB - Libano 3
MA - Marocco 3
UA - Ucraina 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BE - Belgio 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LT - Lituania 1
ME - Montenegro 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.707
Città #
Santa Clara 443
Singapore 404
Hong Kong 174
Hefei 155
San Jose 120
Lauterbourg 84
Ho Chi Minh City 72
Beijing 71
Seoul 68
Hanoi 65
Cavallino 62
Ashburn 46
Afragola 30
Los Angeles 28
Tokyo 28
São Paulo 24
Helsinki 23
Frankfurt am Main 17
Guangzhou 17
Dallas 16
Buffalo 13
Da Nang 13
Lappeenranta 13
Milan 13
New York 13
Council Bluffs 12
Rome 11
Falkenstein 10
Rio de Janeiro 10
Naples 9
Aci Catena 8
Amsterdam 8
Brasília 8
Catania 8
Düsseldorf 8
Hải Dương 8
Johannesburg 8
Minamishinagawa 8
Santo André 8
Bangkok 7
Brooklyn 7
Haiphong 7
Orem 7
Hyderabad 6
Lisle 6
Portsmouth 6
Belo Horizonte 5
Bengaluru 5
Bexley 5
Campinas 5
Cape Town 5
Porto Alegre 5
Ribeirão Preto 5
Araraquara 4
Biên Hòa 4
Boardman 4
Bắc Giang 4
Denver 4
Dhaka 4
Elk Grove Village 4
Jakarta 4
London 4
Ninh Bình 4
Potenza 4
Seattle 4
Thái Nguyên 4
Toronto 4
Wroclaw 4
Abidjan 3
Charlotte 3
Chicago 3
Dublin 3
Fortaleza 3
Guayaquil 3
Isidro Casanova 3
Istanbul 3
Kingston 3
Kuala Selangor 3
Lima 3
Manila 3
Mascalucia 3
Montreal 3
New Delhi 3
Oklahoma City 3
Osaka 3
Pouso Alegre 3
Prague 3
Quito 3
Rio Verde 3
Santiago 3
Shanghai 3
Stockholm 3
Tashkent 3
Thái Bình 3
Warsaw 3
Ahome 2
Alexandria 2
Asunción 2
Baghdad 2
Bitonto 2
Totale 2.368
Nome #
Tear N-glycomics in vernal and atopic keratoconjunctivitis 93
Caratterizzazione strutturale di polisaccaridi mediante spettrometria di massa 89
Phenotypic and genetic spectrum of ATP6V1A encephalopathy: a disorder of lysosomal homeostasis 82
Advances in Purification Methods of Serum Glycoproteins for MALDI-MS Analysis of N- Glycome in Patients with Glycosylation Disorders 77
SLC37A4-CDG: Second patient 77
An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia. 75
The cerebrospinal fluid (CSF) N-glycome as a novel biomarker of Parkinson's disease. A mass spectrometry-based CSF n-glycosylation study of patients affected by Parkinson's disease 72
N-Glycomics of Human Erythrocytes 68
Clinical, molecular and glycophenotype insights in SLC39A8-CDG 67
HILIC-MS based glycomics in the diagnosis of Congenital Disorders of Glycosylation 64
Higher frequency of TMEM199-CDG in the southern mediterranean area is associated with c.92G>C (p.Arg31Pro) mutation 64
CSF N-Glycomics Using MALDI MS Techniques 63
Analisi del Glicoma del Siero di Pazienti Affetti da Disordini Congeniti della Glicosilazione (CDG) e da Galattosemia 63
HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases 63
Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption 61
Lipopolysaccharide from Gut‐Associated Lymphoid‐Tissue‐Resident Alcaligenes faecalis: Complete Structure Determination and Chemical Synthesis of Its Lipid A 60
PROTEOMIC ANALYSIS OF HUMAN TEAR FLUIDS USING LC-MALDI MS AND MS/MS 59
Aberrant sialylation in a patient with a HNF1 alpha variant and liver adenomatosis 59
Combined mass spectrometry methods for serum N-glycoprotein profiling enhance the awareness of the molecular patho-mechanism in ALG12-CDG 59
COG6-CDG: Novel variants and novel malformation 58
CSF N-Glycomics Using High-Throughput UPLC-ESI Techniques in Alzheimer’s Disease 57
Messa a punto di metodi di analisi mediante MALDI TOF ad alta risoluzione sui campioni polisaccaridici IDN 5505 e IDN 5406 frazionati mediante gpc: determinazione dei pesi molecolari; analisi strutturale di due frazioni mediante metodi classici e di spett 56
Secondary disorders of glycosylation in inborn errors of fructose metabolism 54
CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking 54
MALDI-MS CEREBROSPINAL FLUID (CSF) N-GLYCAN PROFILES IN NEURODEGENERATIVE DISEASES 51
N-acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function 51
SLC35A2-CDG: Novel variant and review 50
Studi di stabilità (analisi e caratterizzazione) mediante spettrometria di massa di diverse formulazioni a base di lipidi e/o proteine lacrimali 49
CSF N-Glycoproteomics Using MALDI MS Techniques in Neurodegenerative Diseases 49
The Complete Structure and Pro-inflammatory Activity of the Lipooligosaccharide of the Highly Epidemic and Virulent Gram-Negative Bacterium Burkholderia cenocepacia ET-12 (Strain J2315) 47
Advanced LC-MS Methods for N-Glycan Characterization 44
Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG) 44
ANALISI DEL GLICOMA DEL FLUIDO LACRIMALE IN PAZIENTI AFFETTI DA DISORDINI CONGENITI DELLA GLICOSILAZIONE (CDG) 43
Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis 42
DIFFERENCES IN DISEASE SEVERITY REFLECT DIVERSITY OF GLYCOPROTEOME IN TWO SIBS WITH CDG-Ia 41
Early onset epileptic and developmental encephalopathy and MOGS variants: a new diagnosis in the whole exome sequencing (WES) ERA 41
Identificazione rapida di batteri mediante spettrometria di massa MALDI-TOF: dallo spettro del lipooligosaccaride all individuazione di batteri gram-negativi 40
Biophysical approaches to solve the structures of the complex glycan shield of chloroviruses 40
MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG 40
Hyperkinetic movement disorders in congenital disorders of glycosylation 37
Sighting of unusual glycans 37
ALG12-CDG: novel glycophenotype insights endorse the molecular defect 37
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 36
Minimal Heparin/Heparan Sulfate Sequences for Binding to Fibroblast Growth Factor-1 35
Tay-Sachs CSF N-Glycan Profile by MALDI MS Reveals Incomplete Glycosylation 35
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 35
A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation 35
Identification of N-Glycosylation in the CSF in Patients with Alzheimer's disease by MALDI Mass Spectrometry 34
Tear Fluid N-Glycan Profiling To Investigate Biomarkers In Vernal Keratoconjunctivitis 33
Carbohidrate and Peptide Mapping di lactoferrine naturali e ricombinanti 33
Proteomic of human tear fluids in healthy and pathological conditions 32
Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation 32
Maldi mass spectrometry for the structural investigation of intact lipopolysaccharides 32
Advances in purification methods of serum glycoproteins for MALDI_MS analysis of N-Glycome in patients with glycosylation disorders 31
Red blood cell N-glycan profiling by MALDI-MS 31
Advances in purification methods of serum glycoproteins for MALDI-MS analysis of N- Glycome in CDG patients and in Galactosemia 31
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 31
DETERMINATION OF LINKAGE POSITIONS AND SEQUENCE OF COMPLEX CARBOHYDRATES BY MALDI-TOF-TOF MASS SPECTROMETRY 30
Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides 30
DIFFERENCES IN SEVERITY OF CLINICAL PHENOTYPE REFLECT DIVERSITY OF GLYCOPROTEOME IN TWO SIBS WITH CDG-Ia 30
Mass spectrometry strategies for the N-glycosylation analysis of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and galactosemia 29
Glycomics of human serum: mass spectrometry investigations of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and glactosemia 29
Analisi mediante LC-MS di emulsioni per uso oftalmico 29
Amphiphilic N-glycosyl-thiocarbamoyl cyclodextrins: synthesis, self-assembly, and fluorimetry of recognition by Lens culinaris lectin 29
Cerebrospinal Fluid N-Glycomics May Enable Early Diagnosis in Alzheimer Disease 28
Trattamento di Prodotti Freschi Altamente Deperibili per Garantirne Qualità, Sicurezza e Salubrità (PROFSICURI) 28
Glycoproteomics of congenital disorders of glycosylation and secondary glycosylation disorders 28
Matrix-assisted Laser Desorption/Ionization Mass Spectrometry of Polysaccharides 28
Exopolysaccharides as bacterial defence tools: the case of Burkholderia cepacia Complex . 28
Analisi dei campioni di acido ialuronico coniugati con MTX 27
Full Structural Characterisation of the Lipooligosaccharide of a Burkholderia pyrrocinia Clinical Isolate 27
Silver-Russel sindrome-like features in a patient with abnormal transferrin glycosylation 27
Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype 26
Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype) 26
Novel aspects of the contribution by the lipid A acyl groups to Toll-like receptor 4 activation by lipopolysaccharide 26
Differences in severity of clinical phenotype reflect diversity of glycosylation status in two sibs with phosphomannomutase deficiency (CDG-Ia) due to V129M/R141H mutations 25
Structural relationship of the lipid A acyl groups to activation of murine toll-like receptor 4 by lipopolysaccharides from pathogenic strains of Burkholderia mallei, Acinetobacter baumannii, and Pseudomonas aeruginosa 25
COG5-CDG with a Mild Neurohepatic Presentation 25
CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder 25
Thermophiles as potential source of novel endotoxin antagonists: The full structure and bioactivity of thelipo-oligosaccharide from thermomonas hydrothermalis 25
Mannosidase I deficiency: An unexpected CDG-II with intellectual disability and dysmorphic features 25
DEFICIENCY OF SUBUNIT 6 OF THE CONSERVED OLIGOMERIC GOLGI COMPLEX (COG6-CDG): SECOND PATIENT, DIFFERENT PHENOTYPE 25
Proprietà Strutturali di Polisaccaridi Prodotti dal Batterio Patogeno Opportunista Burkholderia cepacia 25
Detailed characterization of the lipid A fraction from the nonpathogen Acinetobacter radioresistens strain S13 25
The structure of the exocellular polysaccharide from the cyanobacterium Cyanospira capsulata 24
The Outer Membrane of the Marine Gram-Negative Bacterium Alteromonas addita is Composed of a Very Short-Chain Lipopolysaccharide with a High Negative Charge Density 24
Preliminary results on proteomics of human tear fluids : Lack of bioactive peptides and defensins in disease subjects 24
HPLC ANALYSIS OF CYCLIC ADENOSINE-DIPHOSPHATE RIBOSE AND ADENOSINE-DIPHOSPHATE RIBOSE - DETERMINATION OF NAD(+) METABOLITES IN HIPPOCAMPAL MEMBRANES 24
Hypoglycosylation with increate fucosylation and branching of serum transferrin N-glycans in untreated galactosemia 23
Determination of the structure of the O-antigen and the lipid A from the entomopathogenic bacterium Pseudomonas entomophila lipopolysaccharide along with its immunological properties 23
Mass spectrometric strategies for the N-glycosylation analysis of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and galactosemia 22
IDENTIFICATION OF N-ACETYLGLUCOSAMINE AND 4-O-[1-CARBOXYETHYL]MANNOSE IN THE EXOPOLYSACCHARIDE FROM CYANOSPIRA-CAPSULATA 22
Structural elucidation of the core-lipid A backbone from the lipopolysaccharide of Acinetobacter radioresistens S13, an organic solvent tolerant Gram-negative bacterium 21
Structural Analysis of the Deep Rough Lipopolysaccharide from Gram Negative Bacterium Alteromonas macleodii ATCC 27126T: The First Finding of B-Kdo in the Inner Core of Lipopolysaccharides 20
MAN2A2-related glycosylation defects in autism and cognitive delay 6
Glycosylation Pathways Targeted by Deregulated miRNAs in Autism Spectrum Disorder 2
Proteomics of Human Tear Fluids in Healthy and Patological Conditions 2
IgG Glycosylation Analysis in Patients with Ring14 Syndrome Unveils Novel Pathomechanisms and New Therapy Perspectives 1
Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation 1
Totale 3.842
Categoria #
all - tutte 12.309
article - articoli 7.330
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 950
Totale 20.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202433 0 0 0 0 0 0 0 0 3 3 21 6
2024/20251.724 0 2 102 54 417 52 141 111 93 104 342 306
2025/20262.085 104 167 230 286 395 81 326 92 100 133 120 51
Totale 3.842